AI predicts which kids need genetic tests before meds
NCT ID NCT06902688
First seen Mar 06, 2026 · Last updated Apr 28, 2026 · Updated 4 times
Summary
This study tests whether a machine learning model can predict which children in the hospital will need a medication that requires a pharmacogenetic test. The goal is to see if the model helps doctors order these tests earlier, so results are available before the child receives the drug. About 275 children aged 6 months to 18 years at The Hospital for Sick Children will take part. The study focuses on improving the timing of testing, not on treating the disease itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRICS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Hospital for Sick Children
RECRUITINGToronto, Ontario, M5G1X8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.